Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Mauro Mansutti"'
Autor:
Giada Targato, Lucia Bortot, Arianna Dri, Marta Bonotto, Alessandro Marco Minisini, Gianpiero Fasola, Mauro Mansutti
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9630-9639 (2022)
CDK4/6 inhibitors have revolutionized the treatment algorithm of luminal metastatic breast cancer, becoming the recommended first-line therapy in association with endocrine therapy. However, due to its theoretically greater and more rapid tumor shrin
Externí odkaz:
https://doaj.org/article/85cd783bd2554822be9f7ea7672ec840
Autor:
Luca Gianni, Marco Colleoni, Giancarlo Bisagni, Mauro Mansutti, Claudio Zamagni, Lucia Del Mastro, Stefania Zambelli, Giampaolo Bianchini, Antonio Frassoldati, Ilaria Maffeis, Pinuccia Valagussa, Giuseppe Viale
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract The crosstalk between estrogen and HER2 receptors and cell-cycle regulation sustains resistance to endocrine therapy of HER2- and hormone receptor-positive breast cancer. We earlier reported that women with HER2 and ER-positive breast cancer
Externí odkaz:
https://doaj.org/article/e542c52ccbb647d2bea1317628f87e5c
Autor:
Debora Basile, Lorenzo Gerratana, Carla Corvaja, Giacomo Pelizzari, Giorgia Franceschin, Elisa Bertoli, Lorenza Palmero, Diego Zara, Martina Alberti, Silvia Buriolla, Lucia Da Ros, Marta Bonotto, Mauro Mansutti, Simon Spazzapan, Marika Cinausero, Alessandro Marco Minisini, Gianpiero Fasola, Fabio Puglisi
Publikováno v:
Breast, Vol 57, Iss , Pp 104-112 (2021)
Background: Endocrine therapy (ET) plus cyclin-dependent-kinases 4/6 inhibitors (CDK4/6i) represents the standard treatment for luminal-metastatic breast cancer (MBC). However, prospective head-to-head comparisons are still lacking for 1st line (L) o
Externí odkaz:
https://doaj.org/article/ffca05a7c1374d128a76cb6fc5f88ba4
Autor:
Lucia Bortot, Giada Targato, Claudia Noto, Marco Giavarra, Lorenza Palmero, Diego Zara, Elisa Bertoli, Arianna Dri, Claudia Andreetta, Gaetano Pascoletti, Elena Poletto, Stefania Russo, Luca Seriau, Mauro Mansutti, Carla Cedolini, Debora Basile, Gianpiero Fasola, Marta Bonotto, Alessandro Marco Minisini
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundA multidisciplinary team meeting (MDM) approach in breast cancer (BC) management is a standard of care. One of the roles of MDMs is to identify the best diagnostic and therapeutic strategies for patients (pts) with new diagnosis of early BC
Externí odkaz:
https://doaj.org/article/1d1ee3c76c3044ac8d6078ed2cca391f
Autor:
Alberto Ocaña, Jose Ignacio Chacón, Lourdes Calvo, Antonio Antón, Mauro Mansutti, Joan Albanell, María Teresa Martínez, Ainhara Lahuerta, Giancarlo Bisagni, Begoña Bermejo, Vladimir Semiglazov, Marc Thill, Arlene Chan, Serafin Morales, Jesús Herranz, Ignacio Tusquets, Massimo Chiesa, Rosalía Caballero, Pinuccia Valagussa, Giampaolo Bianchini, Emilio Alba, Luca Gianni
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundDerived neutrophil-to-lymphocyte ratio (dNLR) is a biomarker associated with clinical outcome in breast cancer (BC). We analyzed the association of dNLR with pathological complete response (pCR) in triple-negative BC (TNBC) patients receivi
Externí odkaz:
https://doaj.org/article/5764dcbf60e64458b2696da8d2eff802
Autor:
Lucia Del Mastro, Francesca Poggio, Eva Blondeaux, Sabino De Placido, Mario Giuliano, Valeria Forestieri, Michelino De Laurentiis, Adriano Gravina, Giancarlo Bisagni, Anita Rimanti, Anna Turletti, Cecilia Nisticò, Angela Vaccaro, Francesco Cognetti, Alessandra Fabi, Simona Gasparro, Ornella Garrone, Maria Grazia Alicicco, Ylenia Urracci, Mauro Mansutti, Paola Poletti, Pierpaolo Correale, Claudia Bighin, Fabio Puglisi, Filippo Montemurro, Giuseppe Colantuoni, Matteo Lambertini, Luca Boni, M Venturini, A Abate, S Pastorino, G Canavese, C Vecchio, M Guenzi, M Lambertini, A Levaggi, S Giraudi, V Accortanzo, C.A. Floris, E Aitini, G Fornari, S Miraglia, G Buonfanti, M.C. Cherchi, F Petrelli, A Vaccaro, E Magnolfi, A Contu, R Labianca, A Parisi, C Basurto, F Cappuzzo, M Merlano, S Russo, M Mansutti, E Poletto, M Nardi, D Grasso, A Fontana, L Isa, M Comandè, L Cavanna, S Iacobelli, S Milani, G Mustacchi, S Venturini, A.F. Scinto, M.G. Sarobba, P Pugliese, A Bernardo, I Pavese, M Coccaro, B Massidda, M.T. Ionta, A Nuzzo, L Laudadio, V Chiantera, R Dottori, M Barduagni, F Castiglione, F Ciardiello, V Tinessa, A Ficorella, L Moscetti, I Vallini, G Giardina, R Silva, M Montedoro, E Seles, F Morano, G Cruciani, V Adamo, A Pancotti, V Palmisani, A Ruggeri, E Cammilluzzi, F Carrozza, M D'Aprile, M Brunetti, P Gallotti, E Chiesa, F Testore, A D'Arco, A Ferro, A Jirillo, M Pezzoli, G Scambia, C Iacono, P Masullo, G Tomasello, G Gandini, A Zoboli, C Bottero, M Cazzaniga, G Genua, S Palazzo, M D'Amico, D Perrone
Publikováno v:
The Lancet. Oncology. 23(12)
Previous analyses of the GIM (Gruppo Italiano Mammella) 2 study showed that addition of fluorouracil to epirubicin, cyclophosphamide, and paclitaxel in patients with node-positive early breast cancer does not improve outcome, whereas dose-dense chemo
Autor:
Michelino De Laurentiis, Roberta Caputo, Manuelita Mazza, Mauro Mansutti, Riccardo Masetti, Zelmira Ballatore, Rosalba Torrisi, Andrea Michelotti, Alberto Zambelli, Antonella Ferro, Daniele Generali, Patrizia Vici, Luigi Coltelli, Alessandra Fabi, Paolo Marchetti, Alberto Ballestrero, Simon Spazzapan, Antonio Frassoldati, Maria Giuseppina Sarobba, Donatella Grasso, Claudio Zamagni
Publikováno v:
Targeted oncology. 17(6)
Ribociclib plus letrozole demonstrated manageable safety and efficacy profiles in hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC) in the Phase 3b CompLEEment-1 trial.To evaluate
Autor:
Matteo Lambertini, Eva Blondeaux, Giancarlo Bisagni, Silvia Mura, Sabino De Placido, Michelino De Laurentiis, Alessandra Fabi, Anita Rimanti, Andrea Michelotti, Mauro Mansutti, Antonio Russo, Filippo Montemurro, Antonio Frassoldati, Antonio Durando, Stefania Gori, Anna Turletti, Stefano Tamberi, Ylenia Urracci, Piero Fregatti, Maria Grazia Razeti, Roberta Caputo, Carmine De Angelis, Valeria Sanna, Elisa Gasparini, Elisa Agostinetto, Evandro de Azambuja, Francesca Poggio, Luca Boni, Lucia Del Mastro
Publikováno v:
eClinicalMedicine. 59:101931
Autor:
Giuseppe Petruzzellis, Mauro Mansutti, G. Targato, Raffaela Donato, D. Zara, Alessandra Bin, Anna Candoni, Alessandro Marco Minisini, Renato Fanin, Alessandra Sperotto, Giacomo Pelizzari, Chiara Comuzzi, Gianpiero Fasola
Publikováno v:
The Oncologist
Background Triage procedures have been implemented to limit hospital access and minimize infection risk among patients with cancer during the coronavirus disease (COVID‐19) outbreak. In the absence of prospective evidence, we aimed to evaluate the
Autor:
Lucia Del Mastro, Antonio Frassoldati, Giancarlo Bisagni, Mauro Mansutti, Stefania Zambelli, Marco Colleoni, Claudio Zamagni, Luca Licata, Pinuccia Valagussa, Giuseppe Viale, Chanel Smart, Giampaolo Bianchini, Luca Gianni
Publikováno v:
Cancer Research. 80:P4-14
Background We assessed TILs before and during treatment in patients with ER+/HER2+ breast cancer (BC) enrolled in the NA-PHER2 study, and evaluated the association between TILs and their modulation over treatment with likelihood of achieving a pCR. M